Branched polyanhydrides

ABSTRACT

Branched polyanhydrides that have superior properties for use in the controlled delivery of substances, prepared by the polymerization of a dicarboxylic acid monomer and a branching agent. The branching agent is a polycarboxylic acid monomer such as 1,3,5-benzenetricarboxylic acid (&#34;BTC&#34;), or an oligomerized fatty acid trimer. Alternatively, the branching agent is a polycarboxylic acid polymer such as poly(acrylic acid) (&#34;PAA&#34;). These branched polymers have significantly higher molecular weights and lower specific viscosity than linear polymers prepared under similar conditions. A major advantage of branched polyanhydrides is that the degradation and release kinetics can be substantially altered without significantly changing the physical properties of the polymer relative to the corresponding linear polymer. By manipulating both the diacid and the branching agent, a wide variety of biodegradable controlled delivery devices for diverse applications can be prepared.

This is a divisional of copending application Ser. No. 07/532,389 filedin the U.S. Patent and Trademark Office on Jun. 4, 1990, now U.S. Pat.No. 5,175,235, which is a continuation-in-part of U.S. Ser. No.07/467,635, entitled "Polyanhydrides of Oligomerized Unsaturated Acids,"filed on Jan. 19, 1990, now U.S. Pat. No. 5,171,812 by Abraham J. Domb.

BACKGROUND OF THE INVENTION

This invention is in the area of polymers for controlled delivery ofsubstances, and specifically relates to the preparation and use ofbranched polyanhydrides.

There has been extensive research in the area of biodegradablecontrolled release systems for bioactive compounds. Biodegradablematrices for drug delivery are useful because they obviate the need toremove the drug-depleted device. The preferred polymeric matrix combinesthe characteristics of hydrophobicity, stability, strength, flexibility,organic solubility, low melting point, and suitable degradation profile.The polymer must be hydrophobic so that it retains its integrity for asuitable time when placed in an aqueous environment, such as the body,and stable enough to be stored for an extended period before use. Thepolymer must be strong, yet flexible enough that it does not crumble orfragment during use.

Controlled release devices are typically prepared in one of severalways. The polymer can be melted, mixed with the substance to bedelivered, and then solidified by cooling. Melt fabrication requiresthat the polymer have a melting point that is below the temperature atwhich the substance to be delivered and polymer degrade or becomereactive. Alternatively, the device can be prepared by solvent casting,in which the polymer is dissolved in a solvent, and the substance to bedelivered dissolved or dispersed in the solution. The solvent is thenevaporated, leaving the substance in the polymeric matrix. Solventcasting requires that the polymer be soluble in organic solvents.

Many polymers have been evaluated for use as the matrix for a deliverydevice, including polyesters, polyamides, polyurethanes,polyorthoesters, polyacrylonitriles, and polyphosphazenes. None of thesepolymers have exhibited all of the desired characteristics for use inthe controlled delivery of substances.

Polyanhydrides have also been studied for use in controlled deliverydevices, as reported by Leong, et al., J. Med. Biomed. Mater. Res. 19,941 (1985); and J. Med. Biomed. Mater. Res. 20, 51 (1986). One of thefirst polyanhydrides studied for its controlled release behavior waspoly(bis(p-carboxyphenoxy)methane anhydride), described by Rosen, etal., Biomaterials 4, 131 (1983). The aromatic polyanhydride exhibitednear zero order (linear) erosion and release kinetics at 37° C. and 60°C. Shortly thereafter, three related polyanhydrides: poly1,3-(bis(p-carbophenoxy)propane anhydride (p-CPP) (an aromaticpolyanhydride); the polymer formed from the copolymerization of p-CPPwith sebacic acid (a copolymer of an aromatic diacid and an aliphaticdiacid); and polyterephthalic acid (an aromatic anhydride) were preparedand examined for release rates by Leong, et al., J. Med. Biomed. Mater.Res. 19, 941 (1985).

The aromatic polyanhydrides were found to have unacceptably slowdegradation rates. For example, it was estimated that it would take morethan three years for a delivery device prepared from p-CPP to completelydegrade in vivo. Further, anhydride homopolymers based on aromatic orlinear aliphatic dicarboxylic acids were found to be highly crystallineand have poor film forming properties. Aromatic polyanhydrides also havehigh melting points and low solubility in organic solvents.

Polymers prepared from linear aliphatic diacids are hydrophilic solidsthat degrade by bulk erosion, resulting in a rapid release of the drugfrom the polymeric matrix. Hydrophobicity can be increased bycopolymerizing the linear aliphatic diacids with aromatic diacids,however this approach results in an increase in the polymer meltingtemperature and a decrease in solubility in organic solvents.Furthermore, it does not improve the drug release profile but insteadincreases the degradation and the elimination time of the polymer bothin vivo and in vitro. Since both homopolymers and copolymers of linearaliphatic diacids are very sensitive to moisture, they require extremelyanhydrous and low temperature storage conditions.

As described in U.S. Pat. No. 4,757,128 to Domb and Langer, highmolecular weight copolymers of aliphatic dicarboxylic acids witharomatic diacids are less crystalline than aromatic or linear aliphaticpolyanhydrides and they form flexible films. Degradation rates are alsoincreased by copolymerizing an aromatic dicarboxylic acid with analiphatic diacid; however, bulk erosion still occurs because areas ofthe polymer containing aliphatic anhydride linkages erode faster thanaromatic anhydride linkages, leaving channels in the matrix throughwhich the substance to be delivered is released in an uncontrolledfashion. For example, in the p-CPP sebacic acid copolymer, the aliphaticanhydride bonds are cleaved in vivo and all of the drug released in tendays, while the aromatic regions remain intact for another five andone-half months. Further, the copolymers have inferior mechanicalproperties; they become brittle and crumble into flakes on exposure tomoisture.

U.S. Patents that describe the use of polyanhydrides for controlleddelivery of substances include: U.S. Pat. No. 4,857,311 to Domb andLanger, entitled "Polyanhydrides with Improved Hydrolytic DegradationProperties", which describes polyanhydrides with a uniform distributionof aliphatic and aromatic residues in the chain, prepared bypolymerizing a dicarboxylic acid with an aromatic end and an aliphaticend); U.S. Pat. No. 4,888,176 to Langer, Domb, Laurencin, andMathiowitz, entitled "Controlled Drug Delivery High Molecular WeightPolyanhydrides", which describes the preparation of high molecularweight polyanhydrides in combination with bioactive compounds for use incontrolled delivery devices); and U.S. Pat. No. 4,789,724 to Domb andLanger, entitled "Preparation of Anhydride Copolymers", which describesthe preparation of very pure anhydride copolymers of aromatic andaliphatic diacids.

There is clearly a need for a type of polyanhydride that has a highmolecular weight, that also has superior mechanical properties such asflexibility and low specific viscosity. It would also be useful to beable to substantially alter the degradation and release kinetics of thepolyanhydide for a wide variety of applications without significantlyaffecting the physical properties of the polymer.

It is therefore an object of the present invention to provide abiodegradable polymer that releases an incorporated substance in acontrolled manner, having a high molecular weight in combination withsuperior mechanical properties.

It is yet another object of the present invention to provide a polymerwith a degradation and release profile that can be substantially alteredwithout significant alteration of the physical properties of thepolymer.

SUMMARY OF THE INVENTION

Branched polyanhydrides are provided that have superior properties foruse in the controlled delivery of substances in vivo. The branchedpolyanhydrides are prepared by the polymerization of a dicarboxylic acidmonomer and a branching agent. The branching agent is a polycarboxylicacid monomer such as 1,3,5-benzenetricarboxylic acid ("BTC"), or anoligomerized fatty acid trimer, or a polycarboxylic acid polymer such aspolyacrylic acid ("PAA"). Branched polyanhydrides have high molecularweights, in the range of 140,000 to 250,000 weight average molecularweight (M_(w)), but are flexible and pliable. The molecular weights ofthe polymers are substantially higher, and specific viscosity lower,than the corresponding linear polyanhydrides without the branchingagents, and are therefore less brittle and have less of a tendency tocrumble. Films made from branched polyanhydrides containing fatty aciddimers and trimers degrade into a soft film that gradually disappearswithout forming harmful sharp flakes. The lower specific viscosityallows for easier melt fabrication of the controlled delivery device.

These polymers degrade over a period of days, and release incorporatedsubstance at a rate corresponding to their degradation rate. The aqueousdegradation rates and profiles of branched polyanhydrides, as well asthe rates of release of incorporated compound, are manipulated by theselection of the type of dicarboxylic acid and branching agent used toprepare the polymer.

A major advantage of branched polyanhydrides is that the degradation andrelease kinetics can be substantially altered without significantlychanging the physical properties of the polymer relative to thecorresponding linear polymer. By manipulating both the diacid and thebranching agent, a wide variety of biodegradable controlled deliverydevices for diverse applications can be prepared. The solubility canalso be manipulated by controlling the polymerization times. * Branchedpolyanhydrides prepared as described herein are useful in a wide varietyof medical applications, including the controlled delivery of bioactivesubstances and as coatings for implantable devices. The polyanhydridescan also be used for nonmedical applications, including the controlleddelivery of insecticides and fungicides.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1a and 1b is an illustration of the chemical structures ofpoly(sebacic anhydride) branched with 1,3,5-benzenetricarboxylic acid(BTC) and poly(acrylic acid) (PAA).

FIG. 2 is a graph of the weight average molecular weight (×10⁻⁴) versustime of polymerization in minutes for poly(sebacic acid) (p(SA)),poly(sebacic acid) polymerized with 2% by weight of poly(acrylic acid)(P(PAA-2.0%)), and poly(sebacic acid) polymerized with 2.0% by weight to1,3,5-benzenetricarboxylic acid (P(BTC-2.0%)).

FIG. 3 is a graph of the weight average molecular weight (×10⁻⁴) versustime of polymerization for poly(sebacic acid) polymerized with 0.5%,1.0%, 1.5%, and 2.0% 1,3,5-benzenetricarboxylic acid.

FIG. 4 is a graph of the weight average molecular weight (×10⁻⁴ ) versustime of polymerization for poly(sebacic acid) polymerized with 0.5%,1.0%, 1.5%, and 2.0% poly(acrylic acid).

FIG. 5 is a graph of the weight average molecular weight of poly(sebacicacid) branched with poly(acrylic acid) as a function of theconcentration of poly(acrylic acid), taken at fifty-five minutes afterinitiation of polymerization.

FIG. 6 is a graph of the percent degradation of poly(sebacicacid-isophthalic acid-Pripol 1025) (65% SA-ISO in a weight ratio of 9:1and 35% Pripol) and poly(sebacic acid-isophthalic acid-Pripol 1025) (56%SA-ISO in a weight ratio of 9:1 and 44% Pripol) over time at 37° C. andin 0.1 M phosphate buffer, pH 7.4.

FIG. 7 is a graph of the percent degradation of poly(sebacicacid-isophthalic acid-Pripol 1025) (95% SA-ISO in a weight ratio of 9:1and 5% Pripol) over time at 37° C. in 0.1 M phosphate buffer, pH 7.4.

FIG. 8 is a graph of the cumulative percent of morphine released overtime by poly(sebacic acid), and by poly(sebacic acid) branched with0.5%, 1.0%, 1.5%, and 2.0% 1,3,5-benzenetricarboxylic acid, at 37° C. in0.1 M phosphate buffer, pH 7.4.

FIG. 9 is a graph of the cumulative percent of morphine released overtime by poly(sebacic acid), and by poly(sebacic acid) branched with0.5%, 1.0%, 1.5%, and 2.0% poly(acrylic acid) at 37° C. in 0.1 Mphosphate buffer, pH 7.4.

FIG. 10 is a graph of the percent of tetracycline released fromcompressed and melt cast tablets of poly(sebacic acid-isophthalic acid)(9:1 ratio by weight) branched with 0.5% 1,3,5-benzenetricarboxylic acidover time at 37° C. in 0.1 M phosphate buffer, pH 7.4.

FIG. 11 is a graph of the release of methotrexate from poly(sebacicacid-isophthalic acid-Pripol 1025) (95% SA-ISO in a weight ratio of 9:1and 35% Pripol) and poly(sebacic acidisophthalic acid-Pripol 1025) (56%SA-ISO in a weight ratio of 9:1 and 44% Pripol) over time at 37° C. in0.1 M phosphate buffer, pH 7.4.

FIG. 12 is a graph of the release of methotrexate over time frompoly(sebacic acid-isophthalic acid-Pripol 1025) (95% SA-ISO in a weightratio of 9:1 and 5% Pripol) at 37° C. in 0.1 M phosphate buffer, pH 7.4.

FIG. 13 is a graph of the release of marcaine over time frommicroparticles of poly(sebacic acid) crosslinked with 5% and 10%1,3,5-benezenetricarboxylic acid at 37° C. in 0.1 M phosphate buffer, pH7.4.

FIG. 14 is a graph of the release of ibuprofen over time frommicroparticles poly(sebacic acid) crosslinked with 5% and 10%1,3,5-benzenetricarboxylic acid at 37° C. in 0.1 M phosphate buffer, pH7.4.

DETAILED DESCRIPTION OF THE INVENTION

As used here, the term "branched polyanhydride" refers to polyanhydridesprepared by the copolymerization of an aromatic or aliphaticdicarboxylic acid with a polycarboxylic acid monomer or polymer("branching agent"), wherein the polymerization is stopped before thegel point. The term "crosslinked polyanhydride" as used here refers tobranched polyanhydrides that have been allowed to polymerize past thegel point.

Branched polymers are characterized by branch points from which emanatea number of polymer chains in either a random, star like form or acomb-like form. Polyanhydrides prepared with polycarboxylic acidmonomeric branching agents are random copolymers with "star point"emanations. Polyanhydrides prepared with polycarboxylic acid polymericbranching agents are graft copolymers with "comb-like" emanations. Longchain branching results in a decrease in specific viscosity relative tothe corresponding unbranched polymer of similar molecular weight.

Examples of suitable polycarboxylic acids for us in the preparation ofbranched polyanhydrides include 1,3,5-benzenetricarboxylic acid ("BTC"),fatty acid trimers, and poly(acrylic acid) ("PAA") and its derivatives.

The molecular weights of the branched polyanhydrides are significantlyhigher (weight average M_(w) ranging from approximately 150,000 to250,000 for poly(sebacic acid) branched with PAA or BTC) than themolecular weight of linear polymers such as poly(sebacic acid anhydride)p(SA) (weight average M_(w) of 80,000) prepared under the sameconditions. Branched polyanhydrides prepared with certain polycarboxylicacid polymers, for example poly(acrylic acid), exhibit a molecularweight that increases linearly with increasing concentration ofbranching agent.

A substance to be delivered can be incorporated into the matrix of abranched polyanhydride by any appropriate method, including solutionfabrication, melt fabrication, and compression molding. The highlycrosslinked polyanhydrides that are not soluble in organic solvents canbe loaded with the substance to be delivered by swell fabrication. Inthis method, the substance to be delivered is first dissolved in asolution that the crosslinked polyanhydride is not soluble in. Thepolyanhydride is then added to the solution, where it swells, drawingthe solution into its matrix. The solvent is then removed from thepolymer, for example, by evaporation, leaving the substance entrapped inthe polyanhydride matrix.

The release of drug from branched polymers is somewhat slower than fromthe corresponding linear polymers. Longer release times are advantageousin the treatment of certain diseases such as cancer. Drug release fromthe matrix can be manipulated by the proper selection of the branchingagent and the degree of branching in the polymer. For example, therelease of morphine from PAA branched polyanhydrides increases withincreasing concentration of branching agent. The release rate and totalamount of drug released from both PAA and BTC branched sebacic acidpolymers approaches that of the corresponding linear polyanhydridep(SA).

A major advantage of branched polyanhydrides is that the degradation andrelease kinetics can be substantially altered without significantlychanging the physical properties of the polymer relative to thecorresponding linear polymer. By manipulating both the diacid and thebranching agent, a wide variety of biodegradable controlled deliverydevices for diverse applications can be prepared. For example,poly(sebacic acidisophthalic acid) (9:1 by weight) branched withapproximately 9% of the oligomerized fatty acid trimer of oleic aciddegrades faster and releases incorporated substance faster than the samepolymer prepared with 11% of the fatty acid trimer. Poly(sebacic acid)branched with 0.5% of either BTC or PAA is substantially degraded inaqueous buffer after about 20 hours, whereas poly(sebacicacid-isophthalic acid) (9:1 by weight) branched with 5% of theoligomerized fatty acid trimer of oleic acid is only 70% degraded after90 hours.

Biodegradable biocompatible polyanhydride films prepared from branchedor crosslinked polyanhydrides can be used as physical barriers foradhesion prevention (Linsky, C. B., et al., J. Record. Med. 32, 17(1987)). They can also be used for controlled release of drugs,including morphine, tetracyline, ibuprofen, marcaine, methotrexate,dexamethazone and triamcinolone. The release devices can be used toprovide medication to target organs. Examples are films containingheparin for the prevention of blood clotting, and films releasingdexamethasone or cyclosporin to prevent organ transplant rejection.Branched and crosslinked polyanhydride films also are useful in guidedtissue regeneration in periodontal disease (Nyman et al., J. Clin.Perio. 9, 290 (1982); ibid 13, 604 (1986); ibid 14, 618 (1987); ibid 15,288 (1988)) or as tubes for nerve guided regeneration (U.S. Pat. No.4,870,966 to Dellon L. and Mackinnon S. E.).

Branched and crosslinked polyanhydride films can also be used ascoatings for implantable devices, i.e., stents, catheters, artificialvascular grafts, and pacemakers. The coating can release antibiotics,anti-inflammatories, or anti-clotting agents at a predetermined rate, toprevent complications related to the implanted devices. Controlleddelivery devices prepared from these polyanhydrides can also be used asocular inserts for extended release of drugs to the eye.

Branched and crosslinked polyanhydrides are also useful for nonmedicalapplications, including the controlled release of insecticides andfungicides.

The synthesis of the branched polyanhydrides of the present inventionare described in detail as follows:

I. Dicarboxylic Acids

Any dicarboxylic acid can be copolymerized with the appropriatebranching agent to provide a branched or crosslinked polyanhydride.Biocompatible, nontoxic, dicarboxylic acids are preferred for thepreparation of polyanhydrides for medical applications.

Nonlimiting examples of suitable dicarboxylic acids include sebacicacid, adipic acid, isophthalic acid, terephthalic acid, fumaric acid,dodecanedicarboxylic acid, azeleic acid, pimelic acid, suberic acid(octanedioic acid), itaconic acid, biphenyl-4,4'-dicarboxylic acid, andbenzophenone-4,4'-dicarboxylic acid.

Dicarboxylic acids that can be used in the branched polyanhydrideinclude dicarboxylic acids having an aliphatic end and an aromatic end,for example, p-carboxyphenoxyalkanoic acid.

II. Selection of Polycarboxylic Acids Used in the Preparation ofBranched Polyanhydrides

Polycarboxylic acids are used to create branch points in thepolyanhydride matrix. There are several factors to consider whenchoosing a polycarboxylic acid for incorporation into a polyanhydride.First, if the polyanhydride is to be used for a pharmaceutical purpose,for example, for controlled delivery of drugs in vivo, all of thecomponents, including the branching agent, must be biocompatible andnontoxic. Second, the branching agent will influence the rate and extentof release of substance from the polymer.

Polycarboxylic Acid Monomers as Branching Agents

Suitable polycarboxylic acid monomers that can be copolymerized with adicarboxylic acid include 1,3,5-benzenetricarboxylic acid,butane-1,1,4-tricarboxylic acid, tricarballylic acid(propane-1,2,3-tricarboxylic acid), and butane-1,2,3,4-tetracarboxylicacid.

FIGS. 1a and 1b is an illustration of the chemical structures ofpoly(sebacic anhydride) branched with 1,3,5-benzenetricarboxylic acidand with poly(acrylic acid).

As described in copending application U.S. Ser. No. 07/467,635, entitled"Polyanhydrides from Oligomerized Unsaturated Acids," filed on Jan. 19,1990, by Abraham J. Domb, the trimers of naturally occurring unsaturatedfatty acids, such as oleic, erucic, lauroleic, myristoleic, gadoleic,ricinoleic, palmitoleic, linoleic, linolenic, and arachidonic acids, canalso be used to prepare polyanhydrides. These fatty acid derivativesshould be biocompatible and readily eliminated from the body through thenatural digestion mechanism for fatty acids. Oligomerized triacids canbe also be synthesized from non-naturally occurring carboxylic acids,such as acrylic, methacrylic, fumaric, crotonic, vinyl acetic(3-butenoic), isocrotonic, allylacetic (4-pentenoic), hexenoic andundecylenic acids. Naturally occurring and synthetic unsaturated acidscan also be coupled to form a mixed oligomer for use as a branchingagent.

Trimers of oleic acid are very hydrophobic. They add substantialhydrophobicity to polyanhydrides when incorporated into the matrix. As aresult, it is not uncommon to find that the more trimer incorporatedinto the polyanhydride, the longer the release time due to the increasedtime required to wet the matrix.

Trimers of oleic acid are available from commercial sources. UnichemaChemicals, Inc., Chicago, Ill., sells the trimer as Pripol 1025(containing 25% by weight of trimer and 75% dimer) and Pripol 1040 (78%trimer and 22% dimer). Henkel Corporation (LaGrange, Ill.) sellsVersadyme 213, which is 50-70% of the trimer of oleic acid and 25-40%dimer.

Oligomerized unsaturated carboxylic acid monomers can also besynthesized from the corresponding unsaturated acids by methods known tothose skilled in the art.

If the polyanhydride is to be used to deliver other types of substances,including insecticides, fungicides, or pigments, a wide variety ofpolycarboxylic acids can be used, including those named above and othersthat are not biocompatible.

Polycarboxylic Acid Polymers as the Branching Agent

Polymers can also be used as branching agents. The choice of polymerwill be influenced by whether the resulting branched polyanhydride is tobe used for medical applications or nonmedical applications. If thebranched polyanhydride is to be used for the in vivo delivery of abioactive compound, a branching compound should be used that isbiocompatible, nontoxic, and that provides a suitable release profilewhen incorporated into the polymer.

Biocompatible polycarboxylic acid polymers suitable for use in branchedpolyanhydrides for medical applications include poly(acrylic acid),poly(methacrylic acid) poly(maleic acid) and copolymers thereof.

III. Ratio of Branching Agent to Dicarboxylic Acid

Any ratio of dicarboxylic acid to branching agent can be used to preparethe branched polyanhydride, that yields a polyanhydride. The morebranching agent that is used, the more flexible and pliable theresulting polymer. An increase or decrease in branching agent will alsoaffect the degradation and release kinetics of the polymer.

As discussed above, the addition of a small amount of branching agentsignificantly increases the molecular weight of an otherwise linearpolymer. However, if too much branching agent is used, the gel pointwill be reached before there has been sufficient time forpolymerization. The result is a polymer mesh of low molecular weight andinferior physical characteristics. The exact amount of branching agentthat maximizes molecular weight under given reaction conditions and incombination with a selected dicarboxylic acid must be determinedempirically by using methods such as those described in the examplesbelow.

In general, from 0.1 to 15% of branching agent is included in thepolyanhydride. For example, it is preferred to use between 0.1% and 2%BTC or PAA branching agent in combination with sebacic acid in thepreparation of polymeric matrices for the controlled delivery in vivo ofbioactive substances.

IV. Polymerization of Branched Polyanhydrides

Branched polyanhydrides can be prepared by methods known to thoseskilled in the art, including melt polycondensation and solutionpolymerization of the selected dicarboxylic acid with the desired amountof branching agent.

In the method of melt polycondensation, described by Domb, et al., in J.Poly. Sci 25, 3373 (1987), a prepolymer is prepared by heating thediacid and branching agent separately with acetic anhydride to form thecorresponding diacetyldianhydride ("diacid prepolymer") andpolyacetylanhydride ("branching agent prepolymer"). These prepolymersare then mixed and heated neat under vacuum to form a branchedpolyanhydride. Acetic acid is stripped off during the polymerizationprocess. Combinations of diacetyldianhydrides and combinations ofbranching agent prepolymers can also be polymerized with this method.

Solution polymerization is preferred when either the branching agent orthe dicarboxylic acid is sensitive to heat. Solution polymerization isdescribed in U.S. Pat. No. 4,916,204 to Domb et al., entitled "One StepPolymerization of Polyanhydrides." Solution polymerization involves thecoupling of diacids and branching agent with phosgene in an organicsolvent. Poly(4-vinylpyridine-2% divinylbenzene) ("PVP") is added toremove the HCl from solution. For example, diphosgene (0.50 equivalents)is added dropwise to a stirred mixture of diacid (1.0 equivalents) and1,3,5-benzenetricarboxylic acid (0.03 equivalents) andpoly(4-vinylpyridine-2% divinylbenzene) (2.7 equivalents) in 20 ml ofchloroform. The solution is stirred for 3 hours at 25° C. The insolublePVP.HCl is removed by filtration. The solvent is then removed and theprecipitate is isolated, washed with ethyl ether, and then dried at 25°C. for 24 hours in a vacuum oven.

The method of preparation and properties of branched polyanhydrides areillustrated in more detail in the following nonlimiting examples. Forease of illustration and comparison among polymers, sebacic acid is usedas the dicarboxylic acid, 1,3,5-benzenetricarboxylic acid and fatty acidtrimer (Pripol 1025) are used as the tricarboxylic acid monomericbranching agents, and poly(acrylic acid) is used as the polymericbranching agent. However, as stated above, branched polyanhydrides canbe prepared from a large variety of dicarboxylic acids and branchingagents, under a wide variety of reaction conditions.

Sebacic acid, 1,3,5-benzenetricarboxylic acid, and poly(acrylic acid)(MW 2,000) were purchased from Aldrich Chemical Company (Milwaukee,Wis.). Thermal properties of the polymers were determined with adifferential scanning calorimeter (DSC 7, Perkin Elmer, Conn.) using aheating rate of 10° C./min. The molecular weights of the polymers wereestimated with a Waters gel permeation chromatography instrument(Waters, Me.), consisting of a Waters 510 pump and Waters programmablemulti-wavelength detector at 254 nm. Samples were eluted indichloromethane through a Linear Styrogel column (Waters, Me.) at a flowrate of 1.0 ml/min. Molecular weights of polymers were determinedrelative to polystyrene standards (Polysciences, Pa., molecular weightrange, 400 to 1,500,000) using Maxima 840 computer programs (Waters,Me.). The viscosities of the polymers were measured in a 1% solution indichloromethane on a Cannon 50 Ubbelouhde viscometer (Cannon, Pa.) at25° C. Morphine was analyzed according to the USP method using aShimadzu C-R4A HPLC system (Shimadzu, MD) equipped with a C18 column(VWR Scientific, Md.).

Example 1 Preparation of Poly(sebacic acid) Branched with1,3,5-Benzenetricarboxylic Acid and Poly(acrylic acid).

The acetic acid mixed anhydride prepolymers of sebacic acid and thebranching agents were prepared by separate reflux of sebacic acid andthe branching agents in acetic anhydride for 30 minutes. The isolatedprepolymers of BTC and PAA were clear semi-solids. The prepolymer ofsebacic acid was then melt polymerized separately with1,3,5-benzenetricarboxylic acid (BTC) and poly(acrylic acid) (PAA) toyield random and graft type branched polyanhydrides, respectively. Bothbranching agents were mixed with the diacid in the ratios of 0.5%, 1.0%,1.5%, and 2.0% by weight to provide a series of branched polymers.Linear polysebacic acid (p(SA)) was also prepared as a referencepolymer. The melt polymerization was carried out at 180° C. under avacuum of 0.1 mm Hg. The reaction was terminated when the polymerizationreached the gel point.

The progress of polymerization was monitored by withdrawing samples as afunction of time. Each sample was characterized by infraredspectroscopy, gel permeation chromatography, differential scanningcalorimetry, and determination of specific viscosity. The chemicalstructures of the products of these reactions are illustrated in FIGS.1a and 1b.

Table 1 provides the thermal properties and molecular weights of thesynthesized polyanhydrides. As shown, all of the branched polyanhydrideshave significantly higher molecular weights (in the range of 144,300 to263,700 weight average molecular weights) than the reference linearpolyanhydride, p(SA) (M₂ 81,500). The branched polyanhydrides melt attemperatures between 76° and 80° C. Low melting points are verydesirable for melt fabrication of controlled delivery devices. The heatcapacity of the polymers is in the range of 74-118 J/gm, suggesting nomajor differences in the crystallinity of the branched polyanhydridesand the reference linear polyanhydride, p(SA). All of thesepolyanhydrides are highly soluble in methylene chloride and chloroform,and have similar infrared spectra. The specific viscosities of thebranched polyanhydrides are lower than the linear polyanhydrides withsimilar molecular weight.

                  TABLE 1                                                         ______________________________________                                        Thermal Properties and Molecular Weight of Branched                           Polyanhydride.sup.a                                                                                                  Gel                                             T.sub.max                                                                             Molecular Weight                                                                            Specific                                                                              Point                                  Polymer  °C.                                                                            M.sub.n  M.sub.w.sup.b                                                                        Viscosity.sup.c                                                                       (min)                                ______________________________________                                        P(SA)    79      12270     81521 0.742   --                                   P(BTC-0.5%)                                                                            78      40502    216598 1.031   65                                   P(PTC-1.0%)                                                                            78      36830    151922 0.938   45                                   P(BTC-1.5%)                                                                            80      32309    144307 0.806   40                                   P(BTC-2.0%)                                                                            76      32568    263713 0.798   45                                   P(PAA-0.5%)                                                                            78      30606    151071 0.572   80                                   P(PAA-1.0%)                                                                            79      31873    188342 0.790   75                                   P(PAA-1.5%)                                                                            79      31782    203521 0.742   60                                   P(PAA-2.0%)                                                                            76      30513    246828 0.868   60                                   ______________________________________                                         .sup.a Polymerized at 180° C. and under vacuum of 0.1 mm Hg.           .sup.b Molecular Weight was determined by gel permeation chromatography       just before the gel point.                                                    .sup.c Specific viscosity was measured at 25° C. in a 1% w/v           solution in dichloromethane.                                             

EXAMPLE 2 Characterization of Branched Polyanhydrides as a Function ofTime of Polymerization

FIG. 2 is a graph of the molecular weight (×10⁻⁴) versus time ofpolymerization in minutes for poly(sebacic acid) (p(SA)), poly(sebacicacid) polymerized with 2% by weight of poly(acrylic acid) (P(PAA-2.0%),and poly(sebacic acid) polymerized with 2.0% 1,3,5-benzenetricarboxylicacid (P(BTC-2.0%). As shown in FIG. 2, the molecular weight of thebranched polyanhydrides increases during the course of reaction. Therate of increase can be analyzed by dividing the plot into three phasesof reaction. The first phase includes the initial five to ten minutes ofpolymerization. During this time, there is a rapid increase in themolecular weight (to approximately 40,000) as expected with the meltpolycondensation reaction. In the second phase of reaction, during thenext 15 to 20 minutes, molecular weight increases very gradually,indicating the formation of moderately sized oligomers. In the lastphase of the reaction, the time period before the final gel point isreached, there is a sudden increase of molecular weight. This probablyrepresents the reaction between moderately sized segments, following thecomplete exhaustion of sebacic acid prepolymer. In the third phase, avery high molecular weight is attained. Further polymerization resultsin the formation of a gel that is insoluble in common organic solvents.This is probably a result of extensive branching, producing a highlycross-linked material. It is evident that there is a strong influence ofbranching agent on the time necessary to reach a gel point and on themaximum molecular weight.

The polymerization of poly(sebacic acid) was stopped after 90 minutessince continuing the reaction causes a decrease in molecular weight.

EXAMPLE 3 Effect of Concentration of Branching Agent on Polyanhydride

FIG. 3 is a graph of the molecular weight (×10⁻⁴) versus time ofpolymerization for poly(sebacic acid) polymerized with 0.5%, 1.0%, 1.5%,and 2.0% 1,3,5-benzenetricarboxylic acid. FIG. 4 is a graph of themolecular weight (×10⁻⁴) versus time of polymerization for poly(sebacicacid) polymerized with 0.5%, 1.0%, 1.5%, and 2.0% poly(acrylic acid).

As the concentration of BTC increases, the time required to reach thegel point decreases. At every stage of the reaction, the BTC branchedpolymers have higher molecular weights than the corresponding linearpolymer.

A comparison of FIG. 3 and FIG. 4 indicates that the gel time forpolyanhydrides branched with poly(acrylic acid) is relatively longer,and the molecular weight lower, than that for polyanhydrides branchedwith a similar concentration of BTC at a given point of reaction.Further, BTC branched polyanhydrides have higher molecular weights thanPAA branched polyanhydrides of similar concentrations of branchingagents. The molecular weights of p(SA) branched with as little as 0.5%of either BTC or PAA branching agent, however, are much higher than thatof linear p(SA).

The molecular weight of the branched polyanhydrides depends on theconcentration of the branching agent. FIG. 5 is a graph of molecularweight of P(SA) samples, taken at fifty-five minutes afterpolymerization initiation, as a function of the concentration of PAAbranching agent. The molecular weight increases linearly (r² >0.98) as afunction of the concentration of poly(acrylic acid).

EXAMPLE 4 Synthesis of Branched Polyanhydrides using Fatty Acid Trimer

Branched polyanhydrides were synthesized by melt polymerization ofprepolymers of sebacic acid and isophthalic acid with various ratios offatty acid trimer prepolymer (Pripol 1025, Unichema International).Pripol 1025 contains 25% trimer and 75% dimer fatty acid. Therefore, 1/4of the amount of Pripol 1025 used acts as branching agent. The fattyacid dimer that is also in the product is likewise incorporated into thepolymer.

The prepolymer of sebacic acid was prepared as described above. Theisophthalic acid prepolymer was prepared by refluxing 50 grams ofisophthalic acid in 500 ml of acetic anhydride for 10 minutes. Thesolution was then filtered through a sintered glass funnel and theunreacted acetic anhydride removed under vacuum.

The filtered solution solidified at room temperature. This prepolymerwas then further purified by filtration and then recrystallized in 30 mlof toluene and hexane (2:1). The recrystallized pre-polymer was washedwith 200 ml of hexane and ether (9:1) to remove the traces of toluene.

For the polymerization reaction, the ratio of sebacic acid prepolymer toisophthalic acid prepolymer was kept constant at 9:1 by weight. Theamount of Pripol 1025 varied from 0 to 44% by weight. The appropriateamounts of the prepolymers of sebacic acid, isophthalic acid and Pripolwere mixed in a side arm glass test tube. After thorough mixing, theglass test tube was immersed in an oil bath that had been equilibratedat 180° C. After the solids melted, a vacuum of 0.1 mm of Hg was appliedto strip off acetic acid. The reaction was carried out for not more than90 minutes. The resulting polyanhydrides were characterized by specificviscosity, differential scanning calorimetry, NMR, infraredspectroscopy, and gel permeation chromatography. The results areprovided in Table 2.

                  TABLE 2                                                         ______________________________________                                        Thermal Properties and Molecular Weight of Branched                           polymer P(SA-ISO-Pripol 1025).sup.a                                                              Molecular  Other                                                        T.sub.max                                                                           Weight     Physical                                                     °C.                                                                          M.sub.w    Parameter                                       ______________________________________                                        P(SA-ISO)      73.8    130,000    --                                          P(SA-ISO-4.5% Pripol)                                                                        71.95   --         0.35.sup.c                                  P(SA-ISO-9% Pripol)                                                                          70.75   --         0.80.sup.c                                  P(SA-ISO-27% Pripol)                                                                         61.41   Gel        1850.sup.d                                  P(SA-ISO-35% Pripol)                                                                         --      Gel        2000.sup.d                                  P(SA-ISO-44% Pripol)                                                                         --      Gel        --                                          ______________________________________                                         .sup.a Polymerized at 180° C. and under vacuum of 0.1 mm Hg for 90     minutes.                                                                      .sup.b Ratio of prepolymers of SAISO is 9:1.                                  .sup.c Specific Viscosity measured at 25° C. of a 1% w/v solution      in dichloromethane.                                                           .sup.d Swelling constant determined in dichloromethane, representing          percent weight increase.                                                 

III. Degradation and Drug Release Behavior of Branched Polyanhydrides

The degradation and release studies were conducted at 37° C. in 0.1 Mphosphate Buffer, pH 7.4. The buffer was changed at every samplingpoint.

Degradation and release studies of p(SA) branched with BTC and PAA wereconducted on samples loaded with 10% w/w of morphine. Degradation andrelease studies of p(SA) branched with fatty acid trimer were carriedout on samples loaded with methotrexate, tetracycline, marcaine andibuprofen. Unless otherwise stated, the polymers were melt mixed andcast into a rectangular mold. The slabs were cut into 1×1×0.2 mm, eachweighing about 100 mg.

EXAMPLE 5 Aqueous Degradation of Polyanhydrides Branched with Pripol

FIG. 6 is a graph of the percent degradation over time of poly(sebacicacid-isophthalic acid-Pripol 1025) (95% SA-ISO in a weight ratio of 9:1and 5% Pripol) at 37° C. in 0.1 m phosphate buffer, pH 7.4. Asillustrated, the polyanhydride is approximately 50% degraded in lessthan 45 hours. The degradation is approximately linear for almost 100hours.

FIG. 7 is a graph of the percent degradation over time of poly(sebacicacid-isophthalic acid-Pripol 1025) (65% SA-ISO in a weight ratio of 9:1and 35% Pripol) and poly(sebacic acid-isophthalic acid-Pripol 1025) (56%SA-ISO in a weight ratio of 9:1 and 44% Pripol) at 37° C. in 0.1 Mphosphate buffer, pH 7.4. As illustrated, poly(SA-ISO) with more pripolbranching agent (44% by weight) degrades more slowly than that with lessbranching agent (35% by weight). The degradation profile of poly(sebacicacid-isophthalic acid-Pripol 1025) (56% SA-ISO in a weight ratio of 9:1and 44% Pripol) is highly linear for up to 200 hours. The degradationprofile of poly(sebacic acid-isophthalic acid-Pripol 1025) (56% SA-ISOin a weight ratio of 9:1 and 35% Pripol) is approximately linear up to70% degradation (approximately 80 hours).

EXAMPLE 6 Aqueous Degradation of Poly(Sebacic Acid) Crosslinked with 10%and 20% BTC

Poly(sebacic acid) crosslinked with 10% and 20% BTC was prepared asdescribed above, and the rate of degradation over time monitored at 37°C. in 0.1 M phosphate buffer, pH 7.4. Degradation was followed bymonitoring the weight of the particles and by following the ultravioletabsorbance of the BTC in the degradation medium. The rate of degradationwas found to increase with increasing percentage of BTC. The polymerswere completely degraded within 96 hours.

EXAMPLE 7 Release of Morphine from Polyanhydrides Branched with BTC andPAA

FIG. 8 is a graph of the cumulative percent of morphine released overtime from poly(sebacic acid), and from poly(sebacic acid) branched with0.5%, 1.0%, 1.5%, and 2.0% BTC, at 37° C. in 0.1 M phosphate buffer, pH7.4. FIG. 9 is a graph of the cumulative percent of morphine releasedover time by poly(sebacic acid), and by poly(sebacic acid) branched with0.5%, 1.0%, 1.5%, and 2.0% PAA at 37° C. in 0.1 M phosphate buffer, pH7.4.

As shown in FIGS. 8 and 9, as the concentration of BTC and PAA branchingagent increases in the polyanhydride, the cumulative percent of drugreleased increases.

The rate of release of drug from these branched polyanhydrides correlatewith the degradation rates of the polymers. A lag time of about eighthours is observed before significant release of drug occurs. Asmentioned above, this may be a result of the hydrophobicity of thepolymer and the difficulty in wetting the matrix. Once water haspenetrated into the matrix, there is a rapid hydrolysis of the anhydridelinkages that results in a increased release of drug. After about thirtyhours, the release rate gradually decreases until the end of the test.At the end of 196 hours, the test was discontinued because the polymericmatrices fell apart.

On completion of the test, the crumbled matrices were freeze dried andthe amount of morphine remaining in the polymer was determined. Therewas a good correlation between the amount of drug released and theamount left in the polymer, suggesting that the drug is stable in thepolymeric matrix.

The release rates and total amount of drug released from PAA branchedpolyanhydrides (FIG. 9) are higher than that of the corresponding BTCbranched polyanhydrides (FIG. 8). The difference between the release ofdrug from BTC branched polymers and PAA branched polymers is believed tobe a result of differences in the structural framework of the polymers

EXAMPLE 8 Release of Tetracycline from Compressed and Melt Cast Tabletsof Polyanhydrides Branched with BTC

FIG. 10 is a graph of the percent of tetracycline released fromcompressed and melt cast tablets of poly(sebacic acid-isophthalic acid)(9:1 ratio by weight) branched with 0.5% BTC. The release studies wereconducted at pH 5.0 because tetracycline is not stable at higher pH. AtpH 5.0, only 40% of the branched polyanhydride is degraded.

As indicated, the rate and total amount of tetracycline releasedincreases with increasing BTC concentration. The rate and amount oftetracycline released were higher for compression molded tablet thanmelt cast tablets. The release of drug from compression molded tabletsexhibits a burst effect after which the release of drug is fairlylinear. Melt cast tablets exhibit an initial lag time followed by linearrelease for a period of up to 214 hours.

EXAMPLE 9 Release of Methotrexate from Pripol-branched Polyanhydrides

FIG. 11 is a graph of the release of methotrexate over time from meltcast tablets of poly(sebacic acid-isophthalic acid-Pripol 1025) (65%SA-ISO in a weight ratio of 9:1 and 35% Pripol) and poly(sebacicacid-isophthalic acid-Pripol 1025) (56% SA-ISO in a weight ratio of 9:1and 44% Pripol) at 37° C. in 0.1 M phosphate buffer, pH 7.4. FIG. 12 isa graph of the release of methotrexate from poly(sebacicacid-isophthalic acid-Pripol 1025) (95% SA-ISO in a weight ratio of 9:1and 5% Pripol) over time at 37° C. in 0.1 M phosphate buffer, pH 7.4.

The release of drug from all three devices was almost linear. Therelease of drug increased with decreasing concentration of Pripol. Thecumulative amount of drug released varied from 75 to 100% in the first214 hours. The release of methotrexate correlated with the degradationof the polyanhydride matrices, indicative of surface erosion.

V. Incorporation of Drug by Swelling Crosslinked Polymer in Drug LoadedSolution

Substances to be delivered can be incorporated into the matrices ofbranched polyanhydrides by any suitable method, including the knownmethods of solution fabrication, melt fabrication, and compressionmolding.

Branched polyanhydrides that have been polymerized past the gel point toprovide crosslinked polymers are not soluble in organic solvents. Thesecrosslinked polyanhydrides are very useful because they can befabricated "in blank," without substance to be delivered, and thenloaded with the substance at a latter date by swell fabrication. Swellfabrication can be used to prepare size restricted drug loaded devices,including microparticles, microspheres, or nanoparticles. The particlesof desired size are initially prepared from the crosslinkedpolyanhydride without drug. The particle is then loaded with drug by thebelow-described technique, and dried back to its original size. Thisprocedure is especially useful for the incorporation of drugs that aresensitive to mixed solvents, heat, or high shear forces. Branchedpolyanhydrides that are soluble in organic solvents (not polymerizedpast the gel point) cannot be fabricated by this method.

In the method of swell fabrication, the substance to be delivered isdissolved in a solvent that the branched polyanhydride is not solublein, but that causes the polymer to swell. The crosslinked polyanhydridein the form of particles or other matrix of desired shape, is added tothe drug solution. The polymer swells, drawing the solution into thematrix. It is preferred to use a minimal amount of solvent so that allof the solution with drug will be absorbed by the polymer.Alternatively, if more solution is used than can be absorbed by thepolymer, the polymer is retained in the solution with gentle stirringuntil the concentration of drug is constant in the unabsorbed solution.The polymer is then removed from the solvent and vacuum dried at atemperature below which the drug and polymer degrade or react. Thesolvent is removed, leaving the drug in the polymer matrix. The surfacelayer of the drug is then removed by quickly washing the particles orthe device with phosphate buffer.

EXAMPLE 9 Preparation of Delivery Device by Swell Fabrication

Microparticles of poly(sebacic acid) crosslinked with 5% or 10% BTC wereplaced separately into methylene chloride solutions of marcaine andibuprofen (0.5 grams in 1 mL solution). The polymers were allowed toswell. After all of the solvent was absorbed the by the polymerparticles (about 30 minutes), the solvent was evaporated from theparticles using an evaporator. The amount of drug incorporated into thepolymer varied from 63% to 81% of the total amount of drug used.

FIG. 13 is a graph of the release of marcaine over time from crosslinkedpoly(sebacic acid) branched with 5% and 10% BTC at 37° C. in 0.1 Mphosphate buffer, pH 7.4. As indicated, the release of drug from theswell fabricated device increases with increasing concentration of BTC.

FIG. 14 is a graph of the release of ibuprofen from crosslinkedpoly(sebacic acid) branched with 10% and 20% BTC over time at 37° C. in0.1 M phosphate buffer, H 7.4. Both devices released drug gradually overa 24 hour period.

Modifications and variations of the present invention, branched andcrosslinked polyanhydrides and their method of use, will be obvious tothose skilled in the art from the foregoing detailed description. Suchmodifications and variations are intended to come within the scope ofthe appended claims.

We claim:
 1. A polyanhydride for the controlled delivery of substancesprepared by polymerization of a dicarboxylic acid and a compoundselected from the group consisting of a tricarboxylic acid and apolycarboxylic acid branching agent further comprising a substance to bedelivered.
 2. The polyanhydride of claim 1, wherein the branching agentis selected from the group consisting of 1, 3, 5-benzenetricarboxylicacid, butane-1, 1, 4-tricarboxylic acid, tricarballylic acid(propane-1,2,3-tricarboxylic acid), butane-1,2,3,4-tetracarboxylic acid,and oligomerized fatty acid trimers.
 3. The polyanhydride of claim 1,wherein the branching agent is selected from the group consisting ofpoly(acrylic acid), poly (alpha-methacrylic acid), poly(beta-methacrylicacid), and poly (maleic acid).
 4. The polyanhydride of claim 1, whereinthe dicarboxylic acid is selected from the group consisting of sebacicacid, adipic acid, isophthalic acid, p-carboxyphenoxyalkanoic acid,terephthalic acid, fumaric acid, dodecanedicarboxylic acid, azeleicacid, pimelic acid, suberic acid (ocetanedioic acid), itaconic acid,biphenyl-4,¹ -dicarboxylic acid, and benzophenone-4, 4¹ -dicarboxylicacid.
 5. The polyanhydride of claim 1, wherein the substance s abioactive compound.
 6. The polyanhydride of claim 5, wherein thebioactive compound is selected from the group consisting of morphine,tetracyline, ibuprofen, marcaine, methotrexate, dexamethazone andtriamcinolone.
 7. The polyanhydride of claim 1, wherein the substance isincorporated by swell fabrication.